Opto Circuit is currently trading at Rs. 134.65, up by 5.05 points or 3.90% from its previous closing of Rs. 129.60 on the BSE.
The scrip opened at Rs. 129.40 and has touched a high and low of Rs. 135.90 and Rs. 128.55 respectively. So far 366751 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 225.32 on 17-Feb-2012 and a 52 week low of Rs. 114.70 on 29-Aug-2012.
Last one week high and low of the scrip stood at Rs. 135.90 and Rs. 123.55 respectively. The current market cap of the company is Rs. 3265.25 crore.
The promoters holding in the company stood at 28.15% while Institutions and Non-Institutions held 37.29% and 34.56% respectively.
Opto Circuit’s subsidiary, Opto Eurocor Healthcare, has launched its first Sirolimus Drug Eluting Stent (DES), E-MAGIC plus on receipt of Drug Controller General of India (DCGI) license to sell and market products in India. With the launch of E-MAGIC Plus, Opto Circuits becomes one of the few global players to offer DES products with choice of two drugs coatings.
E-MAGIC plus consists of a balloon expandable intra coronary chromium stent pre-mounted on a custom balloon delivery system with a Sirolimus coating (also known as Rapamycin), into the arterial wall. Sirolimus helps control excess growth of cells and allows the artery to heal. Further, E-magic plus stent has an extra edge with soft tip technology to provide smooth access to the lension site ensuring minimal trauma to the vessel wall.
The Sirolimus DES market is estimated to be worth of Rs 800 crore in India. E-Magic has been developed indigenously in India and with DCGI mark; the company can market and sell in India. Meanwhile, the DGCI approval will also enable E-Magic Plus to be marketed in parts of Far East and parts of Middle East.
| Company Name | CMP |
|---|---|
| Poly Medicure | 2581.85 |
| Hemant Surgical Inds | 136.50 |
| Nureca Ltd. | 273.50 |
| Prevest Denpro | 540.00 |
| Centenial Surgical | 125.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
Become a savvy and confident
stock investor.
Don't miss out! First 10 users today get it FREE
Download APP
